Company / Accounts Receivable
Indivior Accounts Receivable History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$253.0M
FY2025
5-year range
$253.0M / $254.0M
FY2023-FY2025
Trend
-0.4%
vs FY2024
Sector context
#30 of 113
Health Care
What the data says
At $253M, Indivior's accounts receivable ranks #30 of 113 in the Health Care sector. Accounts Receivable remained relatively stable over the past 3 years, with values between $253M and $254M.
Based on SEC 10-K filings.
$253M in FY2025.
Remained stable around $253M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#30 of 113 in Health CareTop 27% of 113This company $253.0M Sector average $1.1B
▼
-77.8% below sector average
Key checks
Key Insights
- In FY2025, accounts receivable decreased 0.4% year-over-year.
- Ranks #30 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $253.0M | -0.4% |
| FY2024 | $254.0M | +0.0% |
| FY2023 | $254.0M | - |
| FY2022 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026